Prenetics Global (PRE) Liabilities and Shareholders Equity (2021 - 2026)
Prenetics Global's (PRE) quarterly Liabilities and Shareholders Equity came in at $153.7 million in Q2 2026, down 22.83% year-over-year from $199.1 million in Q2 2025, and down 12.35% quarter-over-quarter from $175.3 million in Q1 2026.
Analysis
Prenetics Global (PRE) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $153.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Liabilities and Shareholders Equity fell 22.83% year-over-year to $153.7 million in Q2 2026; TTM through Jun 2026 was $607.3 million, a 16.02% decrease from a year earlier, with the FY2025 full-year figure at $81.6 million, down 61.79% from the prior year.
- Liabilities and Shareholders Equity was $153.7 million for Q2 2026 at Prenetics Global, down from $175.3 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $291.0 million in Q1 2023 and troughed at $16.3 million in Q4 2022.
- A 5-year average of $202.4 million and a median of $219.8 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
- Across the five-year window, Liabilities and Shareholders Equity sank 89.03% in 2022 and surged 1459.64% in 2023, its largest moves.
- Over 5 years, Liabilities and Shareholders Equity stood at $16.3 million in 2022, then surged by 1459.64% to $254.2 million in 2023, then sank by 67.74% to $82.0 million in 2024, then declined by 0.25% to $81.8 million in 2025, then surged by 87.86% to $153.7 million in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $153.7 million (Q2 2026), $175.3 million (Q1 2026), and $81.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 37.25 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 2.41 Bn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 344.46 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 3.35 Bn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 283.00 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 166.35 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 1.10 Bn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | 30.24 Mn |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | 5.72 Bn |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | 153.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 153.66 Mn |
| Mar 31, 2026 | 175.30 Mn |
| Dec 31, 2025 | 81.79 Mn |
| Sep 30, 2025 | 196.51 Mn |
| Jun 30, 2025 | 199.11 Mn |
| Mar 31, 2025 | 206.20 Mn |
| Dec 31, 2024 | 81.99 Mn |
| Sep 30, 2024 | 235.77 Mn |
| Jun 30, 2024 | 233.31 Mn |
| Mar 31, 2024 | 243.59 Mn |
| Dec 31, 2023 | 254.17 Mn |
| Sep 30, 2023 | 276.41 Mn |
| Jun 30, 2023 | 280.84 Mn |
| Mar 31, 2023 | 291.04 Mn |
| Dec 31, 2022 | 16.30 Mn |
| Sep 30, 2022 | 269.60 Mn |
| Jun 30, 2022 | 278.24 Mn |
| Mar 31, 2022 | 169.58 Mn |
| Dec 31, 2021 | 148.51 Mn |